This post has been archived and contains information that may be out of date.
CHA has submitted comments on the proposed remedy issued by the Centers for Medicare & Medicaid Services (CMS) for its 340B-acquired drug payment policy that was in effect from 2018-2022 for hospitals paid under the outpatient prospective payment system.
This content is restricted to members.
